Delivery Order SPE2DB22D1106-SPE2DB25FEKP4
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,199.06 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FEGU5) is for the procurement of 10,000 units of CHORIONIC GONAD, with a completion date of April 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,086,340.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price and has an ultimate completion date of June 17, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $574,193.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, and no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award, valued at $1,321.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award, valued at $5,296.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of August 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,498,704.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price with an ultimate completion date of April 15, 2024. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,838.53 firm fixed-price delivery order contract has an ultimate completion date of April 22, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 10,000 units of Chorionic Gonad with a potential value of $8,113.20. The contract has a completion date of February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is the prime contractor on this delivery order, which is issued under a larger indefinite...
This federal contract award, valued at $1,401.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract, with a firm fixed price pricing type, and an ultimate completion date of December 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,236.32, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00. The IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare...